Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1206857
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1206857
H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 109 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global H1N1 vaccines market size reached US$ 3.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.11% during 2023-2028.
The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.
Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the H1N1 flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global H1N1 vaccines market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on vaccine type, key brands and market type.
Breakup by Vaccine Type:
- Intramuscular
- Intranasal
- Intradermal
Breakup by Market Type:
- Public
- Private
Analysis of Key Brands:
- Agripal
- Fiuarix
- Influgen
- Influvac
- Nasovac
- Vaxigrip
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
- The report has also examined the competitive landscape of the market and provides the profiles of the key players operating in the industry.
- IMARC Group's latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines industry in any manner.
Key Questions Answered in This Report:
- How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global H1N1 vaccines industry?
- What are the popular vaccines type?
- What are the major market types?
- What are the various stages in the value chain of the global H1N1 vaccines industry?
- What are the key driving factors and challenges in the global H1N1 vaccines market?
- What is the structure of the global H1N1 vaccines industry and who are the key players?
- What is the degree of competition in the industry?
- What are the profit margins in the industry?
Product Code: SR1323A329_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global H1N1 Vaccines Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Breakup by Vaccines Type
- 5.5 Breakup by Market Type
- 5.6 Analysis of Key Brands
- 5.7 Breakup by Region
- 5.8 Market Forecast
6 Market Breakup by Vaccines Type
- 6.1 Intramuscular
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Intranasal
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Intradermal
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Type
- 7.1 Public
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Private
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Europe
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Asia Pacific
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Middle East and Africa
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Latin America
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Analysis of Key Brand
- 9.1 Agripal
- 9.2 Fiuarix
- 9.3 Influgen
- 9.4 Influvac
- 9.5 Nasovac
- 9.6 Vaxigrip
- 9.7 Others
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
- 13.1 Price Indicators
- 13.2 Price Structure
- 13.3 Margin Analysis
14 Industry Developments
- 14.1 Pipeline and New Product Launches
- 14.2 Mergers & Acquisitions and Partnerships
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
Product Code: SR1323A329_Report
List of Figures
- Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
- Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2022
- Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2022
- Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2022
- Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
- Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
- Figure 8: Global: H1N1 Vaccines Industry: Porter's Five Forces Analysis
- Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: H1N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
List of Tables
- Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2023-2028
- Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
- Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 5: Global: H1N1 Vaccines Market Structure
- Table 6: Global: H1N1 Vaccines Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.